The histone demethylase KDM6B preserves adipogenic balance by restraining hypermetabolic LYVE1+ perivascular macrophages
Year: 2026
Type: article
Abstract: White adipose tissue expandability protects against metabolic disease, yet the epigenetic programmes that maintain the macrophage states supporting this adaptation remain poorly defined. Here we show that the H3K27 demethylase KDM6B sustains LYVE1 + adipose tissue perivascular macrophages (PVMs) during diet-induced white adipose tissue expansion, thereby maintaining adipogenic balance. In humans, KDM6B expression in adipose tissue macrophages associates with insulin sensitivity, glycaemic control and reduced inflammation. In mice, myeloid Kdm6b deletion reprogrammes septal and capsular LYVE1 + macrophages towards a CLEC1A + hypermetabolic perivascular state, leading to defective adipogenesis, adipocyte hypertrophy, vascular rarefaction, inflammation and impaired glucose homeostasis. Mechanistically, KDM6B limits H3K27me3 deposition at the Bmp2 locus to maintain macrophage-derived BMP2 signalling to adipose progenitors. Myeloid Bmp2 deletion partially recapitulates Kdm6b -deficient adipose dysfunction, whereas recombinant BMP2 promotes homeostatic tissue remodelling. Collectively, KDM6B acts as an epigenetic switch controlling the metabolic fate of LYVE1 + PVMs, maintaining the balance between adipogenesis-supportive and metabolic PVM states that determine adipose tissue expandability and metabolic homeostasis.
Source: Nature Metabolism
Authors: Bastien Aznar(Investigation, Methodology, Writing – original draft, Writing – review & editing), Zaïneb Mezdari(Investigation, Methodology, Writing – original draft, Writing – review & editing), Jialing He(Investigation, Methodology, Writing – review & editing), Raphaëlle Ballaire(Investigation, Methodology, Writing – review & editing), Marc Diedisheim(Data curation, Writing – review & editing), Denis Anisov(Investigation, Methodology, Writing – review & editing), Lucie Orliaguet(Investigation, Methodology, Writing – review & editing), Claire Leveau(Investigation, Methodology, Writing – review & editing), Jean-Baptiste Julla(Investigation, Methodology, Writing – review & editing), Gerasimos Anagnostopoulos(Investigation, Methodology, Writing – review & editing), Wan Ting Kong(Investigation, Methodology, Writing – review & editing), Magali Chiral(Investigation, Methodology, Writing – review & editing), Lin Chen(Investigation, Methodology, Writing – review & editing), Qi Li(Investigation, Methodology, Writing – review & editing), Dina Chokr(Investigation, Methodology, Writing – review & editing), Ivan Nemazanyy(Investigation, Methodology, Writing – review & editing), Patricia Legoix(Investigation, Methodology, Writing – review & editing), Antoine Soprani(Resources, Writing – review & editing), Daniel Lindén(Investigation, Methodology, Writing – review & editing), Rongrong Fan(Investigation, Methodology, Writing – review & editing), Gilberto Velho(Investigation, Methodology, Resources, Writing – review & editing), Wilfried Le Goff(Investigation, Methodology, Writing – review & editing), Eckardt Treuter(Supervision, Writing – review & editing), Jean-François Gautier(Resources, Supervision, Writing – review & editing), Svetoslav Chakarov(Supervision, Writing – review & editing), Florent Ginhoux(Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing), Amine Toubal(Conceptualization, Data curation, Supervision, Writing – original draft, Writing – review & editing), Nicolas Venteclef(Conceptualization, Data curation, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Institut Necker Enfants Malades, Shanghai Jiao Tong University, Shanghai Institute of Immunology, Institut Cochin, Sorbonne Université, Centre de Recherche des Cordeliers, Institut Gustave Roussy, Assistance Publique – Hôpitaux de Paris, Hôpital Lariboisière, Université Paris-Saclay, Structure fédérative de recherche Necker, Institut Curie, Générale de Santé, AstraZeneca (United Kingdom), Karolinska Institutet, Unité de recherche sur les maladies cardiovasculaires et métaboliques, Fondation pour l’innovation en Cadiométabolisme et Nutrition, Université Paris Sciences et Lettres, AstraZeneca (Sweden), Agency for Science, Technology and Research, Singapore Immunology Network, SingHealth Duke-NUS Academic Medical Centre
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $12,690
Funders: AstraZeneca, Institut Necker-Enfants Malades, Duke-NUS Medical School, Laboratoire d'Excellence Inflamex, Fondation Francophone pour la Recherche sur le Diabète, European Commission, Agency for Science, Technology and Research, European Foundation for the Study of Diabetes, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Cancerfonden, Fondation pour la Recherche Médicale, Karolinska Institutet, Novo Nordisk, Vetenskapsrådet, Centre National de la Recherche Scientifique, Université Paris-Saclay, Institut Gustave-Roussy, Société Francophone du Diabète, Université de Recherche Paris Sciences et Lettres, Novo Nordisk Fonden, Sorbonne Université, National Institutes of Health, Horizon 2020 Framework Programme, Center for Innovative Medicine, National Cancer Institute
Awards: G1072644316, G2578968423, G2910205223, G304773848, G3093238525, G3197512459, G3232492675, Dissecting and targeting functional epigenetics in liver metabolic disorders, G4687045528, G4774453313, G4937468798, Unexplored roles of corepressors in transcriptional regulation and in epigenetic disease mechanisms, Université Sorbonne Paris Cité, NAISS, G9000172134, G954982275
OpenAlex ID: W4417262642
